Literature DB >> 3542299

Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methods.

H A Huebers, M J Eng, B M Josephson, N Ekpoom, R L Rettmer, R F Labbé, P Pootrakul, C A Finch.   

Abstract

We evaluated plasma iron (PI) and total iron-binding capacity (TIBC) or transferrin in normal individuals and in patients with iron imbalance. The standard colorimetric measurements of PI and TIBC and the standard isotope-dilution measurement of TIBC were compared with an immunoprecipitation method and also with immunoelectrophoresis of transferrin. PI concentrations as measured by the standard and immunoprecipitation methods agreed closely for all individuals except those with saturated transferrin, where nontransferrin iron increased the results in the standard assay. This excess iron in saturated plasma may be derived from either free iron or iron-bearing ferritin. There were also differences in TIBC between the two methods. Iron-deficient sera gave higher values for transferrin when measured by immunoelectrophoresis. Unsaturated iron-binding capacity was increased in the isotope-dilution method in some iron-saturated plasma, compounding errors when added to erroneously high PI values to compute TIBC. Perhaps some exchange of iron occurred between added iron and transferrin iron in the isotope-dilution method. These measurements confirm the accuracy of the standard colorimetric method of measuring PI and TIBC except in iron-saturated plasma. However, the greater specificity of a polyclonal immunoprecipitation method of measuring PI and TIBC makes it particularly useful in differentiating transferrin-bound iron from nontransferrin iron.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3542299

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Reference distributions for serum iron and transferrin saturation: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 2.  Markers of iron status in chronic kidney disease.

Authors:  Adam E Gaweda
Journal:  Hemodial Int       Date:  2017-03-22       Impact factor: 1.812

3.  Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.

Authors:  H E Purkey; M I Dorrell; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

4.  Changes in serum parameters associated with iron metabolism in male rat exposed to lead.

Authors:  Minoo Moshtaghie; Pedram Malekpouri; Mohammad Reza Dinko; Ali Asghar Moshtaghie
Journal:  J Physiol Biochem       Date:  2012-09-25       Impact factor: 4.158

5.  Iron absorption in the iron-deficient rat.

Authors:  H A Huebers; E Csiba; B Josephson; C A Finch
Journal:  Blut       Date:  1990-06

6.  The prevalence of anemia and iron deficiency among pregnant Ghanaian women, a longitudinal study.

Authors:  Ruth A Pobee; Jacob Setorglo; Moses Klevor; Laura E Murray-Kolb
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

7.  Metabolic utilization of intravenously injected iron from different iron sources in target tissues of broiler chickens.

Authors:  Lin Lu; Xueyu Dong; Xuelian Ma; Liyang Zhang; Sufen Li; Xugang Luo; Xiudong Liao
Journal:  Anim Nutr       Date:  2021-10-26

8.  Structural analysis of haemoglobin binding by HpuA from the Neisseriaceae family.

Authors:  Chi T Wong; Yingqi Xu; Akshari Gupta; James A Garnett; Steve J Matthews; Stephen A Hare
Journal:  Nat Commun       Date:  2015-12-16       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.